These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15999737)

  • 1. [Measurement of plasma pentosidine and the clinical significance in diagnosis of diabetic nephropathies].
    Sanaka T; Hosokawa T
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():373-8. PubMed ID: 15999737
    [No Abstract]   [Full Text] [Related]  

  • 2. Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.
    Kerkeni M; Saïdi A; Bouzidi H; Letaief A; Ben Yahia S; Hammami M
    Diab Vasc Dis Res; 2013 May; 10(3):239-45. PubMed ID: 23091285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pentosidine].
    Sanaka T; Ishii M; Miyazaki A
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():426-9. PubMed ID: 21667498
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension.
    Busch M; Franke S; Wolf G; Rohde RD; Stein G;
    Nephron Clin Pract; 2008; 108(4):c291-7. PubMed ID: 18434751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end products in children with chronic renal failure and type 1 diabetes.
    Misselwitz J; Franke S; Kauf E; John U; Stein G
    Pediatr Nephrol; 2002 May; 17(5):316-21. PubMed ID: 12042886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of gender, weight, height and BMI on pentosidine concentrations in plasma of hemodialyzed patients.
    Slowick-Zylka D; Safranow K; Dziedziejko V; Dutkiewicz G; Ciechanowski K; Chlubek D
    J Nephrol; 2006; 19(1):65-9. PubMed ID: 16523428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced carbonyl stress in a subpopulation of schizophrenia.
    Arai M; Yuzawa H; Nohara I; Ohnishi T; Obata N; Iwayama Y; Haga S; Toyota T; Ujike H; Arai M; Ichikawa T; Nishida A; Tanaka Y; Furukawa A; Aikawa Y; Kuroda O; Niizato K; Izawa R; Nakamura K; Mori N; Matsuzawa D; Hashimoto K; Iyo M; Sora I; Matsushita M; Okazaki Y; Yoshikawa T; Miyata T; Itokawa M
    Arch Gen Psychiatry; 2010 Jun; 67(6):589-97. PubMed ID: 20530008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The advanced glycation endproduct pentosidine and monocyte activation in uremia.
    Friedlander MA; Witko-Sarsat V; Nguyen AT; Wu YC; Labrunte M; Verger C; Jungers P; Descamps-Latscha B
    Clin Nephrol; 1996 Jun; 45(6):379-82. PubMed ID: 8793229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma advanced glycosylation end-products in maintenance haemodialysis patients.
    Odetti P; Cosso L; Pronzato MA; Dapino D; Gurreri G
    Nephrol Dial Transplant; 1995 Nov; 10(11):2110-3. PubMed ID: 8643178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.
    Miyata T; Ishiguro N; Yasuda Y; Ito T; Nangaku M; Iwata H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):45-9. PubMed ID: 9514872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pentosidine: a new biomarker in diabetes mellitus complications].
    Morales S; García-Salcedo JA; Muñoz-Torres M
    Med Clin (Barc); 2011 Mar; 136(7):298-302. PubMed ID: 20226481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentosidine, carotid atherosclerosis and alterations in left ventricular geometry in hemodialysis patients.
    Zoccali C; Mallamaci F; Asahia K; Benedetto FA; Tripepi G; Tripepi R; Nicocia G; Buemi M; Miyata T
    J Nephrol; 2001; 14(4):293-8. PubMed ID: 11506253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of "carbonyl stress".
    Jadoul M; Ueda Y; Yasuda Y; Saito A; Robert A; Ishida N; Kurokawa K; Van Ypersele De Strihou C; Miyata T
    Kidney Int; 1999 Jun; 55(6):2487-92. PubMed ID: 10354298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive and specific HPLC method for the determination of total pentosidine concentration in plasma.
    Słowik-Zyłka D; Safranow K; Dziedziejko V; Bukowska H; Ciechanowski K; Chlubek D
    J Biochem Biophys Methods; 2004 Nov; 61(3):313-29. PubMed ID: 15571779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is the serum concentration of pentosidine a predictor of cardiovascular events in patients with type 2 diabetes and kidney disease?].
    Busch M; Franke S; Stein G; Wolf G;
    Dtsch Med Wochenschr; 2007 Sep; 132(36):1810-4. PubMed ID: 17726651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia.
    Ueda Y; Miyata T; Hashimoto T; Yamada H; Izuhara Y; Sakai H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Apr; 245(3):785-90. PubMed ID: 9588192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients.
    Nur E; Brandjes DP; Schnog JJ; Otten HM; Fijnvandraat K; Schalkwijk CG; Biemond BJ;
    Br J Haematol; 2010 Oct; 151(1):62-9. PubMed ID: 20678158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma pentosidine levels measured by a newly developed method using ELISA in patients with chronic renal failure.
    Sanaka T; Funaki T; Tanaka T; Hoshi S; Niwayama J; Taitoh T; Nishimura H; Higuchi C
    Nephron; 2002 May; 91(1):64-73. PubMed ID: 12021521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylglyoxal as a prognostic factor in patients with chronic kidney disease.
    Tezuka Y; Nakaya I; Nakayama K; Nakayama M; Yahata M; Soma J
    Nephrology (Carlton); 2019 Sep; 24(9):943-950. PubMed ID: 30407693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dialysis membrane type on plasma concentrations of pentosidine, a marker of carbonyl stress, in hemodialyzed patients.
    Słowik-Zyłka D; Safranow K; Dziedziejko V; Ciechanowski K; Dziewanowski K; Chlubek D
    Pol Arch Med Wewn; 2009 Oct; 119(10):614-20. PubMed ID: 19847136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.